14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DEO vs BUD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
DEO Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 4–5 Matrix Metrics)
DEO Overall Winner
6-Pillar Tally: DEO 4 – 1 BUD (1 Tie)
Matrix Metrics: DEO 4 – 5 BUD
As of Nov 16, 2026, Diageo plc (DEO) is the stronger overall head-to-head candidate over Anheuser-Busch INBEV SA/NV (BUD) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). DEO carries a Unified Composite Score of 33.5/100 (SELL) at $102.15 (16.1x Forward P/E, 29.3% operating margin), whereas BUD carries 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin).
Composite vs. Pillar Nuance: While BUD currently prints a higher short-term Unified Composite Score (34.9/100 SELL vs. DEO 33.5/100 SELL), DEO captures the overall institutional head-to-head verdict (4–5 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (29.3% vs. 26.7% operating margin) and revenue trajectory (-1.7% vs. +9.1% YoY).
Defensive Composite Rating Caution: Although DEO compares more favorably head-to-head, both DEO (33.5/100 SELL) and BUD (34.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DEO vs BUD. Trailing 12-month operating profitability (DEO 29.3% vs BUD 26.7%) and valuation multiples (DEO 16.1x vs BUD 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Beverages - Wineries & Distilleries value chain with $56.6B market capitalization and 29.3% operating margin.
OpEx & R&D Reinvestment30.5% of Rev ($2.51B)
90D Engineering Disclosures0 Published
BUD Moat ProfileScale & Operating Efficiency Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $167.3B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment29.8% of Rev ($19.1B)
90D Engineering Disclosures0 Published
Investor FAQ DEO vs BUD Key Questions & Quantitative Answers
As of Nov 16, 2026, Diageo plc (DEO) is the stronger overall head-to-head candidate over Anheuser-Busch INBEV SA/NV (BUD) in the Tradestie Institutional Equity Comparison Engine, winning 4–5 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). DEO carries a Unified Composite Score of 33.5/100 (SELL) at $102.15 (16.1x Forward P/E, 29.3% operating margin), whereas BUD carries 34.9/100 (SELL) at $84.55 (17.4x Forward P/E, 26.7% operating margin). Composite vs. Pillar Nuance: While BUD currently prints a higher short-term Unified Composite Score (34.9/100 SELL vs. DEO 33.5/100 SELL), DEO captures the overall institutional head-to-head verdict (4–5 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (29.3% vs. 26.7% operating margin) and revenue trajectory (-1.7% vs. +9.1% YoY). Defensive Composite Rating Caution: Although DEO compares more favorably head-to-head, both DEO (33.5/100 SELL) and BUD (34.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
BUD leads the Growth & Scale pillar: DEO posts -1.7% YoY revenue growth and +2.9% YoY earnings growth on $8.24B TTM revenue (59.8% gross margin, 29.3% operating margin), compared with BUD at +9.1% YoY revenue growth and +52.5% YoY earnings growth on $64.0B TTM revenue (56.5% gross margin, 26.7% operating margin). On trailing 12-month operating scale, DEO generates $8.24B in USD-normalized revenue versus $64.0B for BUD. In operating R&D and SG&A reinvestment, DEO deploys 30.5% of Rev ($2.51B) (0 90-day corporate R&D disclosures) versus 29.8% of Rev ($19.1B) (0 disclosures) for BUD.
DEO screens cheaper on headline valuation multiples. DEO trades at 16.1x Forward P/E, 32.6x Trailing P/E, 0.62x PEG, and 6.9x EV/Revenue (32.7% EBITDA margin), whereas BUD trades at 17.4x Forward P/E, 17.3x Trailing P/E, 1.74x PEG, and 2.6x EV/Revenue (31.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DEO (15.0% ROE) versus BUD (11.4% ROE) capital efficiency.
In options market volatility and institutional positioning, DEO carries 25.2% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 33% Vol realized risk). By comparison, BUD carries 23.6% implied volatility (42nd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 33% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.